USD 1.02 billion growth in Gastrointestinal Stromal Tumors Therapeutics (GIST) Market, Increasing awareness campaigns about GIST boosting the growth, 17000 + Technavio ...Middle East

PR Newswire - News
USD 1.02 billion growth in Gastrointestinal Stromal Tumors Therapeutics (GIST) Market, Increasing awareness campaigns about GIST boosting the growth, 17000 + Technavio
Ascentage Pharma, Bayer AG, Blueprint Medicines Corp., and Bristol Myers Squibb Co. are among the key companies NEW YORK, Jan. 25, 2024 /PRNewswire/ -- The gastrointestinal stromal tumors therapeutics market is anticipated to grow by USD 1.02 billion, progressing at a CAGR of 6.01% during...

Hence then, the article about usd 1 02 billion growth in gastrointestinal stromal tumors therapeutics gist market increasing awareness campaigns about gist boosting the growth 17000 technavio was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( USD 1.02 billion growth in Gastrointestinal Stromal Tumors Therapeutics (GIST) Market, Increasing awareness campaigns about GIST boosting the growth, 17000 + Technavio )

Apple Storegoogle play

Last updated :

Also on site :



Latest News